Typhoid, dengue, and common viral fevers share early symptoms like fever and body aches, but differ in cause and severity.

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, ...

A case of membranoproliferative glomerulonephritis with immune depositions in the kidney was reported during clinical trials. Monitor serum creatinine and urinary protein-to-creatinine ratio. If ...

Electroconvulsive therapy is a safe, effective treatment for severe psychiatric conditions like suicidal depression, catatonia, and resistant mania. It induces controlled seizures under anaesthesia, ...

In the European Union (EU) Member States, QDENGA is indicated for the prevention of dengue disease in individuals from four years of age and should be administered subcutaneously as a 0.5 mL dose at a ...

Robust T-Cell Responses, Cross-Variant Durability, and Favorable Safety Profile in Vulnerable Populations ATLANTA, GA - ...

GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that the Phase 2 clinical trial ...

Revaccination with mRNA-1345 against RSV at 12 months was noninferior to primary vaccination among adults aged 50 years and older.

Immune checkpoint inhibitors have shown efficacy in other HPV-related cancers, so a phase 2 trial tested avelumab treatment for locally advanced or metastatic penile cancer.

Of patients with no draining tunnels at baseline, 87.8% still had none at one year, and 90.8% at three years* – indicating sustained symptom relief in these lesions Clinically meaningful improvements ...